Victoria L. Brown

Insider Reports History

Location
Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Victoria Brown
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Victoria L. Brown:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Program Team Lead Common Stock 23,556 $1,500,282 $63.69 20 Jan 2023 Direct

Insider Reports Filed by Victoria L. Brown

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$73,495 4 Program Team Lead 24 Jan 2023, 15:57
APLS Apellis Pharmaceuticals, Inc. 26 Oct 2022 1 -$7,593 4 Program Team Lead 28 Oct 2022, 16:20
APLS Apellis Pharmaceuticals, Inc. 17 Jun 2022 1 -$121,410 4 Program Team Lead 22 Jun 2022, 16:26
APLS Apellis Pharmaceuticals, Inc. 25 Mar 2022 1 -$4,041 4 Program Team Lead 29 Mar 2022, 16:12
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2022 1 -$8,246 4 Program Team Lead 14 Feb 2022, 15:16
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2022 1 -$16,748 4 Program Team Lead 01 Feb 2022, 17:11
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4 Program Team Lead 25 Jan 2022, 15:39
APLS Apellis Pharmaceuticals, Inc. 26 Oct 2021 1 $0 4 Program Team Lead 27 Oct 2021, 16:24